Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
12.51
-0.11 (-0.87%)
Sep 10, 2026, 3:04 PM CST

SHE:002675 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,6662,7412,8693,2763,5833,912
Revenue Growth
-5.85%-4.46%-12.42%-8.58%-8.41%14.42%
Gross Profit
1,4301,3851,3481,3541,5321,588
Operating Income
376.42352.17282.61373.77551.72612.99
Net Income
200.72195.63183.83209.74307.29151.56
Earnings Per Share
0.240.240.220.250.380.19
EPS Growth
25.27%6.42%-12.35%-33.15%101.38%-63.73%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23
API Related Products
892.791,0301,2551,6782,061
Preparatory Products
334.46369.81325.49400.16483.26
Radio Pharmaceutical Products
1,1751,1281,0121,017914.9
Others
332.2281.4275.98180.6123.77
Offset of Business Segment
--68.19---
Total
2,6662,7412,8693,2763,583

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
884.411,097905.55664.531,049955.88
Total Debt
1,316776.32899.96792.23683.251,049
Net Cash (Debt)
-431.41320.835.59-127.7365.7-93.39
Net Cash Growth
-5638.53%----
Net Cash Per Share
-0.520.390.01-0.150.45-0.12

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
374.53579.85287.15276.94996.54943.58
Capital Expenditures
-379.08-360.82-456.09-511.95-389.61-530.16
Free Cash Flow
-4.55219.03-168.94-235606.93413.42
Free Cash Flow Growth
----46.80%33.20%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
53.62%50.52%46.97%41.34%42.77%40.59%
Operating Margin
14.12%12.85%9.85%11.41%15.40%15.67%
Pretax Margin
8.40%7.71%7.64%10.30%12.44%9.10%
Profit Margin
7.53%7.14%6.41%6.40%8.58%3.87%
FCF Margin
-0.17%7.99%-5.89%-7.17%16.94%10.57%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0810.0810.0800.1250.1500.150
Dividend Per Share Growth
0.78%0.78%-36.00%-16.67%0%-40.00%
Dividend Yield
0.62%0.59%0.66%0.70%0.94%0.99%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
51.7157.9254.8272.0744.4483.52
Forward PE
29.3535.9232.6235.7930.3928.05
P/FCF Ratio
-51.73--22.5030.62
PS Ratio
3.904.133.514.613.813.24